Wednesday, 29 April 2026European Markets
Search

EU Antitrust Scrutiny Looms Over Global Hearing Care Consolidation as Amplifon Eyes Expansion

Regulatory authorities across multiple European jurisdictions are expected to scrutinize potential hearing care consolidation that would create a vertically integrated global player. Amplifon CEO Enrico Vita faces medium-likelihood regulatory challenges including potential divestitures or transaction blocking in key EU markets.<sup>1</sup>

Salvado
Salvado

March 18, 2026

EU Antitrust Scrutiny Looms Over Global Hearing Care Consolidation as Amplifon Eyes Expansion
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

European competition authorities are poised to examine hearing care industry consolidation that could create a fully integrated global operator, with regulatory intervention carrying medium likelihood across multiple jurisdictions.

Amplifon, led by CEO Enrico Vita, operates in a sector where vertical integration—combining retail hearing aid dispensing with manufacturing or supply chain control—raises antitrust red flags in Brussels and national capitals. The European Commission has historically scrutinized healthcare consolidation for potential harm to consumer choice and pricing.

Regulatory challenges could manifest as mandatory divestitures of overlapping retail networks in countries where market concentration exceeds thresholds, typically 25-40% depending on national competition law. Transaction blocking remains possible if authorities conclude remedies cannot address competitive concerns.

The hearing care sector has seen steady consolidation over the past decade, with private equity-backed chains and multinational operators acquiring independent audiologists across Europe. Vertical integration intensifies scrutiny because it can foreclose competitors from supply chains or retail channels.

EU merger control applies when combined turnover exceeds €5 billion globally and €250 million in the EU, triggering mandatory pre-merger notification. National authorities in Germany, France, Italy and Spain maintain parallel jurisdiction over healthcare retail transactions affecting their markets.

Amplifon operates across 26 countries with over 9,000 points of sale, making it a significant player in European hearing care retail. Any consolidation creating a "truly global vertically integrated" entity would likely require multi-jurisdictional filings and face Phase II investigations in major markets.

The assessment reflects major severity given potential impacts on market structure, though medium likelihood suggests consolidation paths exist that could satisfy regulatory requirements through structural or behavioral remedies.

Salvado
Salvado

Tracking how AI changes money.